Section editor, Glen Spielmans, PhD. Dr. Spielmans has disclosed that he has no relevant financial or other interests in any commercial companies ertaining to this educational activity.
Two recent meta-analyses compared second-generation antidepressants (SGADs) to each other regarding efficacy and safety.
Viibryd has gone generic, but is it worth prescribing? We review all there is to know about vilazodone in this update from our #1 most read article of 2023.